Skip to main content
. Author manuscript; available in PMC: 2014 Sep 11.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Oct 6;(10):CD008039. doi: 10.1002/14651858.CD008039.pub2
Methods Multicentre, randomised, double-blind (double-dummy), placebo-controlled, parallel-group. Single oral dose
Medication taken when migraine of moderate or severe intensity
Assessments at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, and 4 hours
If pain not controlled, participants asked to wait 2 hours before taking rescue medication (of participant’s choice)
Participants Migraine with and without aura (IHS 1988). History: attack at least once every 2 months during past year. Untreated attacks ≥ moderate severity
N = 1559
M 306, F 1249
Mean age 38 years
History of aura: 21%
Interventions Ibuprofen 2 × 200 mg, n = 669
Paracetamol + aspirin + caffeine 2 × 250/250/65 mg, n = 669
Placebo, n = 221
Outcomes Pain-free at 2 hours
Presence of nausea, vomiting, photophobia, phonophobia
Adverse events
Withdrawals
Notes Oxford Quality Score: R1, DB2, W1. Total = 4
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Not described
Allocation concealment? Unclear Not described
Blinding?
All outcomes
Yes Double-dummy method